Suba Krishnan

Suba Krishnan brings more than 20 years of experience in clinical pediatric hematology/oncology and oncology drug development to her role at Bright Peak. She was most recently VP of Early Clinical Development at Eikon Therapeutics, where she led strategy and clinical development of a novel selective PARP1 inhibitor and other small molecule programs in the early oncology pipeline. Prior to that, she served as Senior Vice President of Clinical Development at Mereo Biopharma, where she oversaw their rare disease (alpha1 antitrypsin deficiency-associated lung disease) and anti-TIGIT antibody efforts for oncology. At Genmab she served as VP and Global Program Head, Immuno-oncology, where she led clinical strategy and development of multiple pre-clinical and clinical stage programs including the novel IO duobody GEN1042. Prior to Genmab, she held roles of increasing responsibility including at Merck where she led the evaluation of a HRRm/HRD-based selection biomarker panel for Lynparza; at Medimmune/AZ where she led the early clinical development of multiple ADCs and IO programs including, among others; and at Bristol-Myers Squibb, where she initially served as the clinical lead for the early phases of development of T-cell agonist antibodies including GITR and CD137 (urelumab) and ran the Phase-1 RDE combination cohort of ipilimumab and nivolumab in advanced melanoma; and subsequently, served as the clinical lead for the filing of nivolumab in 2L urothelial carcinoma, and led the initial study design and early execution of late phase checkpoint inhibitor combo studies in GU malignancies. Suba received her MBBS from Armed Forces Medical College, Pune University, India. She completed her pediatric residency at Children’s Hospital of Michigan in Detroit, MI and her pediatric hematology/oncology fellowship at Morgan Stanley Children’s Hospital, Columbia University, New York which included extensive research experience in the laboratory of Katherine Hajjar in the Cell and Developmental Biology Program at Cornell University. Prior to her career in Pharma, Suba held faculty positions at the Departments of Pediatric Hematology at Columbia University, New York, and Thomas Jefferson University in Philadelphia.